Inicio › Cáncer de vejiga › Oklahoma › Oklahoma City
Ensayos clínicos de Cáncer de vejiga en Oklahoma City, OK
11 estudios para Cáncer de vejiga buscan participantes en centros de Oklahoma City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
The Vanguard Study: Testing a New Way to Screen for Cancer
ReclutandoSe aceptan voluntarios sanos
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
ReclutandoFase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
ReclutandoFase 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Mercy Hospital Oklahoma City, Oklahoma City
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
ReclutandoFase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
ReclutandoFase 2
- University of Oklahoma Health Sciences Center, Oklahoma City
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
ReclutandoFase 1
- University of Oklahoma - Health Sciences Center, Oklahoma City
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
ReclutandoFase 3
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
ReclutandoFase 2
- OU Health Stephenson Cancer Center, Oklahoma City
- OU Medical Center, Oklahoma City
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
ReclutandoFase 1
- OU Health University of Oklahoma Medical Center, Oklahoma City
- Stephenson Cancer Center (chemo location), Oklahoma City
- University of Oklahoma Health Science Center, Oklahoma City
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
ReclutandoEstudio observacional
- Mercy Hospital - OKC, Oklahoma City
Más información sobre Cáncer de vejiga en MedlinePlus
Ensayos de Cáncer de vejiga en otras ciudades
- New York City, NY35 estudios
- Nashville, TN31 estudios
- Houston, TX31 estudios
- Dallas, TX27 estudios
- Washington, DC26 estudios
- Boston, MA26 estudios
- Baltimore, MD24 estudios
- Los Angeles, CA24 estudios
- St. Louis, MO22 estudios
- Seattle, WA21 estudios
- Philadelphia, PA21 estudios
- Chicago, IL21 estudios
Otros estudios en Oklahoma City
- Cáncer de pulmón de células no pequeñas28 estudios
- Cáncer de ovario28 estudios
- Cáncer de endometrio25 estudios
- Cáncer del colon y del recto22 estudios
- Cáncer de próstata21 estudios
- Cáncer de pulmón19 estudios
- Cáncer de seno17 estudios
- Cáncer metastásico16 estudios
- Cáncer (todos los tipos)14 estudios
- Leucemia mielógena aguda14 estudios
- Carcinoma de células escamosas de cabeza y cuello13 estudios
- Cáncer de páncreas11 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.